BX795 is primarily used in research settings as a potent and selective inhibitor of TBK1 (TANK-binding kinase 1) and IKKε (IκB kinase epsilon). Its application is significant in studying signaling pathways involved in inflammation, immune responses, and cancer. Researchers utilize BX795 to investigate the role of TBK1/IKKε in cellular processes such as autophagy, antiviral responses, and tumorigenesis. It is also employed to explore potential therapeutic targets for diseases like rheumatoid arthritis, lupus, and certain cancers. Additionally, BX795 helps in understanding the mechanisms of innate immunity and the regulation of interferon production. Its use in experimental models provides insights into the development of novel treatments for inflammatory and immune-related disorders.